Compare Stocks: LNSR, OBIO, OFIX, and MOBI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LNSR LENSAR	$7.07 -0.3%	$7.05	$4.95 ▼ $12.94	$86.86M	0.97	90,057 shs	124,413 shs
MOBI Mobia Medical	$10.54 -2.9%	$11.34	$9.85 ▼ $15.29	$350.89M	N/A	174,449 shs	1.72 million shs
OBIO Orchestra BioMed	$6.08 +5.2%	$4.70	$2.20 ▼ $6.30	$365.44M	0.54	305,150 shs	1.14 million shs
OFIX Orthofix Medical	$8.71 +0.8%	$10.33	$8.50 ▼ $16.99	$354.78M	0.64	298,999 shs	610,246 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LNSR LENSAR	0.00%	-6.97%	-16.23%	+23.17%	-44.20%
MOBI Mobia Medical	0.00%	+5.29%	-3.74%	-26.04%	+1,053,999,900.00%
OBIO Orchestra BioMed	0.00%	-0.65%	+11.97%	+52.38%	+147.15%
OFIX Orthofix Medical	0.00%	-2.46%	-12.99%	-7.83%	-41.70%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LNSR LENSAR	$7.07 -0.3%	$7.05	$4.95 ▼ $12.94	$86.86M	0.97	90,057 shs	124,413 shs
MOBI Mobia Medical	$10.54 -2.9%	$11.34	$9.85 ▼ $15.29	$350.89M	N/A	174,449 shs	1.72 million shs
OBIO Orchestra BioMed	$6.08 +5.2%	$4.70	$2.20 ▼ $6.30	$365.44M	0.54	305,150 shs	1.14 million shs
OFIX Orthofix Medical	$8.71 +0.8%	$10.33	$8.50 ▼ $16.99	$354.78M	0.64	298,999 shs	610,246 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LNSR LENSAR	0.00%	-6.97%	-16.23%	+23.17%	-44.20%
MOBI Mobia Medical	0.00%	+5.29%	-3.74%	-26.04%	+1,053,999,900.00%
OBIO Orchestra BioMed	0.00%	-0.65%	+11.97%	+52.38%	+147.15%
OFIX Orthofix Medical	0.00%	-2.46%	-12.99%	-7.83%	-41.70%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LNSR LENSAR	2.33	Hold	$11.50	62.66% Upside
MOBI Mobia Medical	2.57	Moderate Buy	$20.75	96.87% Upside
OBIO Orchestra BioMed	2.75	Moderate Buy	$13.17	116.56% Upside
OFIX Orthofix Medical	2.40	Hold	$14.75	69.35% Upside

Current Analyst Ratings Breakdown

Latest LNSR, OBIO, OFIX, and MOBI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/15/2026	OBIO Orchestra BioMed	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/15/2026	OBIO Orchestra BioMed	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$10.00 ➝ $11.00
9/11/2026	OFIX Orthofix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/10/2026	OBIO Orchestra BioMed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/26/2026	OFIX Orthofix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/21/2026	LNSR LENSAR	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/20/2026	LNSR LENSAR	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$9.00 ➝ $10.00
8/13/2026	LNSR LENSAR	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$13.00
8/13/2026	LNSR LENSAR	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $9.00
8/12/2026	MOBI Mobia Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
8/12/2026	MOBI Mobia Medical	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$15.00 ➝ $17.00

(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LNSR LENSAR	$58.44M	1.49	N/A	N/A	($2.18) per share	-3.24
MOBI Mobia Medical	$32.04M	10.95	N/A	N/A	N/A	∞
OBIO Orchestra BioMed	$33.48M	10.91	N/A	N/A	$0.95 per share	6.40
OFIX Orthofix Medical	$822.31M	0.43	N/A	N/A	$11.30 per share	0.77

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LNSR LENSAR	-$34.28M	-$0.33	N/A	N/A	N/A	57.57%	-529.08%	50.03%	11/12/2026 (Estimated)
MOBI Mobia Medical	-$46.50M	-$20.18	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OBIO Orchestra BioMed	-$52.70M	-$0.85	N/A	N/A	N/A	-184.60%	-149.61%	-54.15%	11/9/2026 (Estimated)
OFIX Orthofix Medical	-$92.19M	-$1.54	N/A	N/A	N/A	-7.41%	-14.05%	-7.17%	11/3/2026 (Estimated)

Latest LNSR, OBIO, OFIX, and MOBI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	LNSR LENSAR	-$0.1650	$0.10	+$0.2650	$0.10	$14.65 million	$16.50 million
8/11/2026	Q2 2026	MOBI Mobia Medical	-$0.83	-$1.10	-$0.27	-$1.10	N/A	$13.51 million
8/10/2026	Q2 2026	OBIO Orchestra BioMed	-$0.3920	-$0.38	+$0.0120	-$0.38	$0.14 million	$0.09 million
8/5/2026	Q2 2026	OFIX Orthofix Medical	-$0.4099	-$0.39	+$0.0199	-$0.39	$209.28 million	$210.93 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
MOBI Mobia Medical	N/A	N/A	N/A	N/A	N/A
OBIO Orchestra BioMed	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LNSR LENSAR	N/A	2.39	1.13
MOBI Mobia Medical	0.04	13.28	12.80
OBIO Orchestra BioMed	1.80	8.26	8.24
OFIX Orthofix Medical	0.55	2.84	1.67

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LNSR LENSAR	40.15%
MOBI Mobia Medical	N/A
OBIO Orchestra BioMed	53.20%
OFIX Orthofix Medical	89.76%

Insider Ownership

Company	Insider Ownership
LNSR LENSAR	65.80%
MOBI Mobia Medical	N/A
OBIO Orchestra BioMed	7.50%
OFIX Orthofix Medical	2.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LNSR LENSAR	150	12.29 million	4.20 million	Optionable
MOBI Mobia Medical	167	33.29 million	N/A	N/A
OBIO Orchestra BioMed	4	60.10 million	55.60 million	Not Optionable
OFIX Orthofix Medical	1,605	40.73 million	39.63 million	Optionable

LNSR, OBIO, OFIX, and MOBI Headlines

Recent News About These Companies

Stifel维持Orthofix Medical买入评级，目标价$13

September 16, 2026 | cn.investing.com

Orthofix Medical Inc. (NASDAQ:OFIX) Given Average Rating of "Hold" by Analysts

September 16, 2026 | marketbeat.com

Bank of New York Mellon Corp Takes Position in Orthofix Medical Inc. $OFIX

September 11, 2026 | marketbeat.com

BlackRock Inc. Takes Position in Orthofix Medical Inc. $OFIX

September 2, 2026 | marketbeat.com

3,300,499 Shares in Orthofix Medical Inc. $OFIX Purchased by Paradigm Capital Management Inc. NY

August 25, 2026 | marketbeat.com

135,241 Shares in Orthofix Medical Inc. $OFIX Purchased by Great Lakes Advisors LLC

August 23, 2026 | marketbeat.com

Orthofix Medical Inc. (NASDAQ:OFIX) Given Consensus Recommendation of "Hold" by Analysts

August 22, 2026 | marketbeat.com

Orthofix Medical (NASDAQ:OFIX) Insider Patrick Fisher Sells 1,295 Shares of Stock

August 21, 2026 | insidertrades.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (OFIX), Rhythm Pharmaceuticals (RYTM) and Viatris (VTRS)

August 11, 2026 | theglobeandmail.com

Orthofix raises 2026 outlook after Q2 sales growth

August 6, 2026 | beckersspine.comB

Orthofix: Q2 Earnings Snapshot

August 5, 2026 | houstonchronicle.comH

Orthofix Medical Inc. Q2 2026 Earnings Call Summary

August 5, 2026 | finance.yahoo.com

Orthofix forecasts $845M-$855M 2026 net sales, supported by $15M Europe MDR inventory order

August 5, 2026 | seekingalpha.com

Bet on 5 Top-Ranked Stocks With Rising P/E

August 5, 2026 | zacks.com

Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates

August 5, 2026 | zacks.com

Orthofix Medical (OFIX) Gets a Buy from Canaccord Genuity

July 29, 2026 | theglobeandmail.com

Orthofix Medical (OFIX) Receives a Buy from Barrington

July 29, 2026 | theglobeandmail.com

Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for

July 29, 2026 | zacks.com

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

July 29, 2026 | prnewswire.com

Can Orthofix Medical (NASDAQ:OFIX) Capitalize on A Key Medicare Shift?

July 27, 2026 | kalkinemedia.comK

Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement Cut

July 24, 2026 | uk.finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LNSR, OBIO, OFIX, and MOBI Company Descriptions

LENSAR NASDAQ:LNSR

$7.07 -0.02 (-0.28%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$7.07 0.00 (0.00%)

As of 09/18/2026 04:10 PM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Mobia Medical NASDAQ:MOBI

$10.54 -0.32 (-2.95%)

As of 09/18/2026 04:00 PM Eastern

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.

Orchestra BioMed NASDAQ:OBIO

$6.08 +0.30 (+5.19%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$6.05 -0.03 (-0.48%)

As of 09/18/2026 07:30 PM Eastern

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Orthofix Medical NASDAQ:OFIX

$8.71 +0.07 (+0.81%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$8.71 0.00 (0.00%)

As of 09/18/2026 07:30 PM Eastern

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LNSR, OBIO, OFIX, and MOBI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LNSR, OBIO, OFIX, and MOBI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LNSR, OBIO, OFIX, and MOBI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LNSR, OBIO, OFIX, and MOBI Company Descriptions

LENSAR NASDAQ:LNSR

Mobia Medical NASDAQ:MOBI

Orchestra BioMed NASDAQ:OBIO

Orthofix Medical NASDAQ:OFIX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LNSR, OBIO, OFIX, and MOBI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LNSR, OBIO, OFIX, and MOBI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LNSR, OBIO, OFIX, and MOBI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LNSR, OBIO, OFIX, and MOBI Company Descriptions

LENSAR NASDAQ:LNSR

Mobia Medical NASDAQ:MOBI

Orchestra BioMed NASDAQ:OBIO

Orthofix Medical NASDAQ:OFIX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools